市場調査レポート

商品コード

1771309

バイオセンサー市場：業界動向と世界の予測 - バイオセンサータイプ別、エンドユーザータイプ別、主要地域別

Biosensors Market: Industry Trends and Global Forecasts - Distribution by Type of Biosensors, Type of End User and Key Geographical Regions

出版日: 2025年07月15日
発行: Roots Analysis
ページ情報: 英文 217 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,799 712,507円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (One-Location Site License)

USD 6,999 1,039,141円

レポートPDFを同一所在地における特定事業ユニットに属する全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Department License)

USD 10,599 1,573,633円

レポートPDFを部署単位で12名様までご利用いただけるライセンスです。同一部署内であれば、地理的に同じ地点に存在する必要はありません。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 17,999 2,672,311円

レポートPDFを同社の国内外拠点における全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.47円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のバイオセンサー市場：概要

世界のバイオセンサーの市場規模は、2035年までの予測期間中に9.0%のCAGRで拡大し、現在の59億米ドルから2035年までに140億米ドルに成長すると予測されています。

この市場セグメンテーションでは、市場規模と機会分析を以下のパラメータで区分しています：

バイオセンサータイプ

光学バイオセンサー
電気化学バイオセンサー
サーマルバイオセンサー
その他

エンドユーザー

学術研究機関
業界参入企業

主要地域

北米
欧州
アジア太平洋
中東・北アフリカ
ラテンアメリカ
その他の地域

世界のバイオセンサー市場：成長と動向

長年にわたり、医薬品開発や疾病診断において薬理学的分子を同定するためのハイスループットスクリーニング手法や高度な分析ツールの普及が進み、バイオセンサーの需要が急増しています。バイオセンサーは、抗体、細胞、酵素、脂質、オリゴヌクレオチドなどの生物学的要素と物理的変換器とを組み合わせた分析装置です。電気化学バイオセンサー、光学バイオセンサー、熱バイオセンサーなどのバイオセンサー技術の進歩により、生物学的ターゲットの同定と検証が容易になっています。さらに、バイオセンサーのリアルタイム分析能力は、研究者が医薬品開発のために潜在的な生物学的標的を迅速に同定するのに役立ち、エラーの可能性を排除しながら高い精度を保証します。創薬におけるバイオセンサーの重要性から、現在、複数の利害関係者が、何千ものヒット化合物から主要な医薬品候補をスクリーニングし、リード化合物を最適化するためにバイオセンサーの利用を模索しています。

さらに、創薬開発プロセスにバイオセンシング技術を導入することで、正確なスクリーニングが可能になり、研究開発活動全体が強化されると予想されていることは興味深いです。80を超えるバイオセンサーが、医薬品開発の目的で利用可能であるか、複数の利害関係者によって開発されています。さらに、この分野には過去5年間に主要な産業および非産業参入企業によって12億米ドル以上が投資されています。バイオセンサー市場の参入企業がこの分野で積極的に取り組んでいることから、市場は予測期間中に成長すると予想されます。

バイオセンサーの世界市場：主要インサイト

この調査レポートは、世界のバイオセンサー市場の現状を詳細に調査し、産業内の潜在的な成長機会を特定しています。本レポートの主な調査結果は以下の通りです。

現在、創薬に焦点を当てた80以上のバイオセンサーが世界中の様々な企業により開発されています。
この市場で入手可能なデバイスの65％近くが光学式バイオセンサーであり、これらのバイオセンサー技術の90％以上が新薬のリード化合物の同定をサポートしています。
15％以上のバイオセンサーが創薬の全工程をサポートすると主張しています。このようなバイオセンサー開発企業の例としては、Malvern Panalytical、Invitrometrix、Nicoya Lifesciencesなどがあります。
主要参入企業の50％以上が北米を拠点としており、そのうち約70％の企業が光学および電気化学バイオセンシング技術を創薬に利用しています。
市場情勢は、2005年以降に設立された小規模企業が支配的です。米国は、バイオセンサーに焦点を当てた創薬の重要な拠点として浮上しており、最大規模の開発企業が存在します。

競争優位性を獲得するため、バイオセンサー開発企業は現在、既存の能力を拡大し、それぞれの製品ポートフォリオを増強する取り組みを行っています。
長年にわたり、この分野に携わる参入企業は、既存のバイオセンサー技術の開発をさらに進め、改良を可能にするために様々な取り組みを行ってきました。
いくつかの投資家は、この将来性のある分野でのビジネスチャンスに気づき、過去4年間にさまざまな資金調達ラウンドで12億米ドル以上を投資しています。
資金調達活動は着実に増加しており、特に2024年には、業界関係者は合計で6億米ドル近くを調達しました。
約1億8,500万米ドルがベンチャー・ラウンドを通じて調達され、このうち83％がベンチャー・シリーズAから調達されました。
北米では、資金調達ラウンドの大半（82％）が米国を拠点とする組織により主導され、11億米ドルに相当する金額が投資されました。
発表された科学文献は、進化する創薬開発のニーズに応えるため、新しいバイオセンサー技術を発見しようとする研究者の積極的な取り組みを示しています。
創薬におけるバイオセンサーの使用に関連する論文の55％以上が過去2年間に発表されており、その大部分（60％）は研究論文でした。
様々な業界関係者や非業界関係者が複数の世界イベントに参加し、創薬におけるバイオセンサーの使用に関連する研究成果、関連する課題、機会について議論しています。
創薬用途に特化した様々なバイオセンサー技術について、主に北米を拠点とする企業により350件以上の特許が付与／出願されています。
また、特許の16％は世界知的所有権機関（WIPO）に出願されています。
創薬バイオセンサー市場は、2035年までCAGR 9%で成長すると予想されています。この機会は、バイオセンサータイプ、エンドユーザー、地域別十分に分散されると考えられます。

バイオセンサーの世界市場：主要セグメント

バイオセンサータイプ別では、市場は光学バイオセンサー、電気化学バイオセンサー、熱バイオセンサー、その他に区分されます。現在、光学式バイオセンサー分野が世界のバイオセンサー市場で最大（～70％）のシェアを占めています。この動向は今後も変わらないと思われます。

エンドユーザーのタイプによって、市場は学術・研究機関と産業参入企業に区分されます。現在、学術・研究機関セグメントがバイオセンサー市場で最も高い割合（～60％）を占めています。さらに、業界参入企業のセグメントは、予測期間中に10.1%という高い複合年間成長率で成長すると予測されています。

主要地域別に見ると、市場は北米、欧州、アジア太平洋、ラテンアメリカ、中東・北アフリカ、その他の地域に区分されます。現在、北米（～40％）がバイオセンサー市場を独占し、最大の収益シェアを占めています。さらに、欧州の市場は今後数年間、より高いCAGRで成長すると予想されています。

バイオセンサー市場の参入企業例

Agilent Technologies
Axion Biosystems
BioNavigations
Creoptix
Cytiva
Dynamic Biosensors
Malvern Panalytical
Microvacuum
Sartorius
Tempo Bioscience

当レポートでは、世界のバイオセンサー市場について調査し、市場の概要とともに、バイオセンサータイプ別、エンドユーザータイプ別動向、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

章の概要
予測調査手法と主要な前提条件
創薬市場における世界のバイオセンサー（2035年まで）
- 創薬市場におけるバイオセンサー：バイオセンサータイプ別
- 創薬市場におけるバイオセンサー：エンドユーザー別
- 創薬市場におけるバイオセンサー：地域別

第13章結論

第14章エグゼクティブ洞察

第15章付録1：表形式データ

第16章付録2：企業・団体一覧

図表

List of Tables

Table 4.1 Biosensors in Drug Discovery: List of Companies
Table 4.2 Biosensors in Drug Discovery: Information on Type of Biosensor, Bioreceptor used, Drug Discovery Step(s) and Other Applications Supported
Table 4.3 Biosensors in Drug Discovery: Information on Type of Analyte
Table 4.4 Biosensors in Drug Discovery: Information on Carrier Plate Format, Sample Capacity, Sample Volume, Type of Detection Method Employed and Type of System
Table 6.1 Leading Biosensor Developers
Table 6.2 Agilent Technologies: Company Overview
Table 6.3 Agilent Technologies: Product Portfolio
Table 6.4 Agilent Technologies: Recent Developments and Future Outlook
Table 6.5 Axion Biosystems: Company Overview
Table 6.6 Axion Biosystems: Product Portfolio
Table 6.7 BioNavigations: Company Overview
Table 6.8 BioNavigations: Product Portfolio
Table 6.9 Creoptix: Company Overview
Table 6.10 Creoptix: Product Portfolio
Table 6.11 Creoptix: Recent Developments and Future Outlook
Table 6.12 Cytiva: Company Overview
Table 6.13 Cytiva: Product Portfolio
Table 6.14 Cytiva: Recent Developments and Future Outlook
Table 6.15 Dynamic Biosensors: Company Overview
Table 6.16 Dynamic Biosensors: Product Portfolio
Table 6.17 Dynamic Biosensors: Recent Developments and Future Outlook
Table 6.18 Malvern Panalytical: Company Overview
Table 6.19 Malvern Panalytical: Product Portfolio
Table 6.20 Malvern Panalytical: Recent Developments and Future Outlook
Table 6.21 Microvacuum: Company Overview
Table 6.22 Microvacuum: Product Portfolio
Table 6.23 Sartorius: Company Overview
Table 6.24 Sartorius: Product Portfolio
Table 6.25 Sartorius: Recent Developments and Future Outlook
Table 6.26 Tempo Bioscience: Company Overview
Table 6.27 Tempo Bioscience: Product Portfolio
Table 8.1 Biosensors in Drug Discovery: List of Funding and Investments, Since 2018
Table 9.1 Biosensors in Drug Discovery: List of Recent Publications, Since 2018
Table 10.1 Biosensors in Drug Discovery: List of Global Events, Since 2021
Table 11.1 Patent Analysis: Prominent CPC Symbols
Table 11.2 Patent Analysis: Most Popular CPC Symbols
Table 11.3 Patent Analysis: List of Top CPC Symbols
Table 11.4 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.5 Patent Portfolio: List of Leading Patents (in terms of Highest Relative Valuation)
Table 11.6 Patent Portfolio: List of Leading Patents (in terms of Number of Citations)
Table 14.1 Efferent Labs: Company Snapshot
Table 14.2 Montana Molecular: Company Snapshot
Table 14.2 Domain Therapeutics: Company Snapshot
Table 15.1 Biosensor Developers for Drug Discovery Applications: Distribution by Year of Establishment
Table 15.2 Biosensor Developers for Drug Discovery Applications: Distribution by Company Size
Table 15.3 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Region-wise)
Table 15.4 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Country-wise)
Table 15.5 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters and Company Size
Table 15.6 Most Active Players: Distribution by Number of Biosensors Developed
Table 15.7 Biosensors in Drug Discovery: Distribution by Type of Biosensor
Table 15.8 Biosensors in Drug Discovery: Distribution by Type of Bioreceptor Used
Table 15.9 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Type of Bioreceptor Used
Table 15.10 Biosensors in Drug Discovery: Distribution by Drug Discovery Step(s) Supported
Table 15.11 Biosensors in Drug Discovery: Distribution by Other Applications Supported
Table 15.12 Biosensors in Drug Discovery: Distribution by Type of Analyte
Table 15.13 Biosensors in Drug Discovery: Distribution by Carrier Plate Format
Table 15.14 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Carrier Plate Format
Table 15.15 Biosensors in Drug Discovery: Distribution by Sample Capacity
Table 15.16 Biosensors in Drug Discovery: Distribution by Sample Volume
Table 15.17 Biosensors in Drug Discovery: Distribution by Type of Detection Method Employed
Table 15.18 Biosensors in Drug Discovery: Distribution by Type of System
Table 15.19 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, Since 2018
Table 15.20 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, Since 2018 (USD Million)
Table 15.21 Funding and Investment Analysis: Distribution of Funding Instances by Type of Funding
Table 15.22 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Table 15.23 Funding and Investment Analysis: Distribution of Funding Instances by Type of Biosensor
Table 15.24 Most Active Players: Distribution by Number of Funding Instances
Table 15.25 Most Active Players: Distribution by Amount Invested (USD Million)
Table 15.26 Most Active Investors: Distribution by Number of Funding Instances
Table 15.27 Funding and Investment Analysis: Distribution of Amount Invested by Region (USD Million)
Table 15.28 Funding and Investment Analysis: Distribution of Amount Invested by Country (USD Million)
Table 15.29 Publication Analysis: Distribution by Year of Publication
Table 15.30 Publication Analysis: Distribution by Type of Publication
Table 15.31 Most Popular Journals: Distribution by Number of Publications
Table 15.32 Most Popular Journals: Distribution by Impact Factor
Table 15.33 Publication Analysis: Most Popular Keywords
Table 15.34 Most Active Publisher: Distribution by Number of Publications
Table 15.35 Most Active Affiliated Institutes: Distribution by Number of Publications
Table 15.36 Publication Analysis: Distribution by Geography
Table 15.37 Global Event Analysis: Cumulative Quarterly Trend
Table 15.38 Global Event Analysis: Distribution by Event Platform
Table 15.39 Global Event Analysis: Distribution by Type of Event
Table 15.40 Global Event Analysis: Distribution by Location of Event
Table 15.41 Most Active Organizers: Distribution by Number of Events
Table 15.42 Global Event Analysis: Distribution by Designation of Participants
Table 15.43 Global Event Analysis: Distribution by Affiliated Department of Participants
Table 15.44 Global Event Analysis: Geographical Mapping of Upcoming Events
Table 15.45 Patent Analysis: Distribution by Type of Patent
Table 15.46 Patent Analysis: Distribution by Patent Publication Year
Table 15.47 Patent Analysis: Distribution by Geography
Table 15.48 Patent Analysis: Distribution by CPC Symbols
Table 15.49 Patent Analysis: Distribution by Patents Age
Table 15.50 Patent Analysis: Distribution by Type of Applicant
Table 15.51 Leading Industry Players: Distribution by Number of Patents
Table 15.52 Leading Non-Industry Players: Distribution by Number of Patents
Table 15.53 Leading Individual Assignees: Distribution by Number of Patents
Table 15.54 Biosensors in Drug Discovery: Patent Valuation Analysis
Table 15.55 Global Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.56 Biosensors in Drug Discovery Market: Distribution by Type of Biosensor
Table 15.57 Optical Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.58 Electrochemical Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.59 Thermal Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.60 Other Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.61 Biosensors in Drug Discovery Market: Distribution by Type of End User
Table 15.62 Biosensors in Drug Discovery Market for Academic and Research Institutions, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.63 Biosensors in Drug Discovery Market for Industry Players, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.64 Biosensors in Drug Discovery Market: Distribution by Region
Table 15.65 Biosensors in Drug Discovery Market in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.66 Biosensors in Drug Discovery Market in Europe, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.67 Biosensors in Drug Discovery Market in Asia Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.68 Biosensors in Drug Discovery Market in Latin America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.69 Biosensors in Drug Discovery Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 15.70 Biosensors in Drug Discovery Market in Rest of the World, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)

List of Figures

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Funding and Investments
Figure 2.3 Executive Summary: Publication Analysis
Figure 2.4 Executive Summary: Global Event Analysis
Figure 2.5 Executive Summary: Patent Analysis
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Components of Biosensors
Figure 3.2 Electrochemical Biosensor
Figure 3.3 Thermal Biosensor
Figure 3.4 Optical Biosensor
Figure 3.5 Piezo-electric Biosensor
Figure 3.4 Resonant Biosensor
Figure 4.1 Biosensor Developers for Drug Discovery Applications: Distribution by Year of Establishment
Figure 4.2 Biosensor Developers for Drug Discovery Applications: Distribution by Company Size
Figure 4.3 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters and Company Size
Figure 4.6 Most Active Players: Distribution by Number of Biosensors Developed
Figure 4.7 Biosensors in Drug Discovery: Distribution by Type of Biosensor
Figure 4.8 Biosensors in Drug Discovery: Distribution by Type of Bioreceptor Used
Figure 4.9 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Type of Bioreceptor Used
Figure 4.10 Biosensors in Drug Discovery: Distribution by Drug Discovery Step(s) Supported
Figure 4.11 Biosensors in Drug Discovery: Distribution by Other Applications Supported
Figure 4.12 Biosensors in Drug Discovery: Distribution by Type of Analyte
Figure 4.13 Biosensors in Drug Discovery: Distribution by Carrier Plate Format
Figure 4.14 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Carrier Plate Format
Figure 4.15 Biosensors in Drug Discovery: Distribution by Sample Capacity
Figure 4.16 Biosensors in Drug Discovery: Distribution by Sample Volume
Figure 4.17 Biosensors in Drug Discovery: Distribution by Type of Detection Method Employed
Figure 4.18 Biosensors in Drug Discovery: Distribution by Type of System
Figure 5.1 Product Competitiveness Analysis: Dot Plot Analysis
Figure 5.2 Product Competitiveness Analysis: Biosensors in Drug Discovery
Figure 7.1 Biosensor Developers for Drug Discovery Applications: Brand Positioning Matrix
Figure 7.2 Brand Positioning Matrix: Agilent Technologies
Figure 7.3 Brand Positioning Matrix: Cytiva
Figure 7.4 Brand Positioning Matrix: Sartorius
Figure 7.5 Brand Positioning Matrix: Malvern Panalytical
Figure 8.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, Since 2018
Figure 8.2 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, Since 2018 (USD Million)
Figure 8.3 Funding and Investment Analysis: Distribution of Funding Instances by Type of Funding
Figure 8.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 8.5 Funding and Investment Analysis: Distribution of Funding Instances by Type of Biosensor
Figure 8.6 Most Active Players: Distribution by Number of Funding Instances
Figure 8.7 Most Active Players: Distribution by Amount Invested (USD Million)
Figure 8.8 Most Active Investors: Distribution by Number of Funding Instances
Figure 8.9 Funding and Investment Analysis: Distribution of Amount Invested by Region (USD Million)
Figure 8.10 Funding and Investment Analysis: Distribution of Amount Invested by Country (USD Million)
Figure 9.1 Publication Analysis: Distribution by Year of Publication
Figure 9.2 Publication Analysis: Distribution by Type of Publication
Figure 9.3 Most Popular Journals: Distribution by Number of Publications
Figure 9.4 Most Popular Journals: Distribution by Impact Factor
Figure 9.5 Publication Analysis: Most Popular Keywords
Figure 9.6 Most Active Publisher: Distribution by Number of Publications
Figure 9.7 Most Active Affiliated Institutes: Distribution by Number of Publications
Figure 9.8 Publication Analysis: Distribution by Geography
Figure 10.1 Global Event Analysis: Cumulative Quarterly Trend
Figure 10.2 Global Event Analysis: Distribution by Event Platform
Figure 10.3 Global Event Analysis: Distribution by Type of Event
Figure 10.4 Global Event Analysis: Distribution by Location of Event
Figure 10.5 Global Event Analysis: Distribution by Evolutionary Trends in Event Agenda / Key Focus Area
Figure 10.6 Most Active Organizers: Distribution by Number of Events
Figure 10.7 Global Event Analysis: Distribution by Designation of Participants
Figure 10.8 Global Event Analysis: Distribution by Affiliated Department of Participants
Figure 10.9 Global Event Analysis: Geography of Upcoming Events
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Distribution by Patent Publication Year
Figure 11.3 Patent Analysis: Distribution by Geography
Figure 11.4 Patent Analysis: Distribution by CPC Symbols
Figure 11.5 Patent Analysis: Emerging Focus Areas
Figure 11.6 Patent Analysis: Distribution by Patents Age
Figure 11.7 Patent Analysis: Distribution by Type of Applicant
Figure 11.8 Leading Industry Players: Distribution by Number of Patents
Figure 11.9 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.10 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.11 Biosensors in Drug Discovery: Patent Valuation Analysis
Figure 12.1 Global Biosensors in Drug Discovery Market, Till 2035 (USD Billion)
Figure 12.2 Biosensors in Drug Discovery Market: Likely Growth Scenarios
Figure 12.3 Biosensors in Drug Discovery Market: Distribution by Type of Biosensor (USD Billion)
Figure 12.4 Optical Biosensors in Drug Discovery Market, Till 2035 (USD Billion)
Figure 12.5 Electrochemical Biosensors in Drug Discovery Market, Till 2035 (USD Billion)
Figure 12.6 Thermal Biosensors in Drug Discovery Market, Till 2035 (USD Billion)
Figure 12.7 Other Biosensors in Drug Discovery Market, Till 2035 (USD Billion)
Figure 12.8 Biosensors in Drug Discovery Market: Distribution by Type of End User
Figure 12.9 Biosensors in Drug Discovery Market for Academic and Research Institutes, Till 2035 (USD Billion)
Figure 12.10 Biosensors in Drug Discovery Market for Industry Players, Till 2035 (USD Billion)
Figure 12.11 Biosensors in Drug Discovery Market: Distribution by Region
Figure 12.12 Biosensors in Drug Discovery Market in North America, Till 2035 (USD Billion)
Figure 12.13 Biosensors in Drug Discovery Market in Europe, Till 2035 (USD Billion)
Figure 12.14 Biosensors in Drug Discovery Market in Asia Pacific, Till 2035 (USD Billion)
Figure 12.15 Biosensors in Drug Discovery Market in Latin America, Till 2035 (USD Billion)
Figure 12.16 Biosensors in Drug Discovery Market in Middle East and North Africa, Till 2035 (USD Billion)
Figure 12.17 Biosensors in Drug Discovery Market in Rest of the World, Till 2035 (USD Billion)
Figure 13.1 Concluding Remarks: Market Landscape
Figure 13.2 Concluding Remarks: Funding and Investments Analysis
Figure 13.3 Concluding Remarks: Publication Analysis
Figure 13.4 Concluding Remarks: Global Event Analysis
Figure 13.5 Concluding Remarks: Patent Analysis
Figure 13.6 Concluding Remarks: Market Forecast and Opportunity Analysis

Product Code: RA100362

GLOBAL BIOSENSORS MARKET: OVERVIEW

As per Roots Analysis, the biosensors market is estimated to grow from USD 5.9 billion in the current year to USD 14 billion by 2035, at a CAGR of 9.0% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Biosensor

Optical Biosensors
Electrochemical Biosensors
Thermal Biosensors
Others

Type of End User

Academic and Research Institutes
Industry Players

Key Geographical Regions

North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
Rest of the World

GLOBAL BIOSENSORS MARKET: GROWTH AND TRENDS

Over the years, the growing prevalence of high throughput screening methodologies and advanced analytical tools to identify pharmacological molecules during drug development and disease diagnosis has led to a surge in demand for biosensors. Biosensors are analytical devices that consist of biological elements like antibodies, cells, enzymes, lipids, or oligonucleotides, combined with a physical transducer. With advances in biosensor technology, such as electrochemical biosensors, optical biosensors and thermal biosensors, identifying and validating biological targets has become easier. Moreover, the real-time analysis ability of biosensors helps researchers in rapid identification of potential biological targets for drug development, ensuring high precision while eliminating the chances of errors. Owing to its significance in drug discovery, several industrial stakeholders are currently exploring the use of biosensors in screening the leading drug candidates from thousands of hits and lead optimization.

Further, it is interesting to note that implementing biosensing technologies in the drug development and discovery process is anticipated to enhance the overall R&D activities by enabling accurate screening. Over 80 biosensors are available or are being developed by several industrial stakeholders for drug development purposes. Additionally, more than USD 1.2 billion has been invested in this field by key industrial and non-industrial players within the past five years. Given the active approach undertaken by the biosensors market players in this domain, the market is anticipated to grow during the forecast period.

GLOBAL BIOSENSORS MARKET: KEY INSIGHTS

The report delves into the current state of global biosensors market and identifies potential growth opportunities within industry. Some key findings from the report include:

Presently, more than 80 biosensors, focused on drug discovery applications, are being developed by various companies across the world; 65% of such biosensors are capable of analyzing small molecules.
Nearly 65% of the available devices in this market are optical biosensors; over 90% of these biosensor technologies support the identification of new drug leads.
More than 15% of the biosensors claim to support all the steps in drug discovery; examples of such biosensor developers include Malvern Panalytical, Invitrometrix and Nicoya Lifesciences.
More than 50% of the key players are based in North America; of these, around 70% of the companies are using optical and electrochemical biosensing technologies for drug discovery.
The market landscape is dominated by small players, which were established post 2005; the US has emerged as a key hub for drug discovery focused on biosensors, featuring the presence of maximum developers.

In pursuit of gaining a competitive edge, biosensor developers are presently undertaking initiatives to expand their existing capabilities and augment respective product portfolios.
Over the years, players engaged in this domain have carried out a variety of initiatives to further advance the development / enable improvement of their existing biosensor technologies.
Several investors, having realized the opportunity within this upcoming segment, have invested over USD 1.2 billion across various funding rounds in the past four years.
There has been a steady increase in the funding activity; specifically, in 2024, industry players collectively raised close to USD 0.6 billion.
Around USD 185 million was raised through venture rounds; of this, 83% funding was raised from venture series A.
In North America, majority (82%) of the funding rounds were led by organizations based in the US, having invested amount worth USD 1.1 billion.
Published scientific literature signifies the active initiatives of researchers to discover new biosensor technologies in order to cater to the evolving drug discovery and development needs.
Over 55% of articles related to use of biosensor in drug discovery have been published in the last two years; majority (60%) of the publications were research papers.
Various industry and non-industry players have participated in multiple global events to discuss research outcomes, affiliated challenges and opportunities associated with the use of biosensors in drug discovery.
More than 350 patents have been granted / filed for various biosensor technologies focused on drug discovery applications, primarily by players based in North America.
Nearly 85% of the total patents have been filed in developed regions, such as the US and Europe; Additionally, 16% of the patents have been filed in World Intellectual Property Organization (WIPO).
The market for biosensors in drug discovery is expected to grow at a CAGR of 9%, till 2035; the opportunity is likely to be well-distributed across different types of biosensors, end users and geographies.

GLOBAL BIOSENSORS MARKET: KEY SEGMENTS

Optical Biosensors Segment Occupies the Largest Share of the Biosensors Market

Based on the type of biosensor, the market is segmented into optical biosensors, electrochemical biosensors, thermal biosensors and others. At present, optical biosensors segment holds the maximum (~70%) share of the global biosensors market. This trend is likely to remain same in the coming future.

By Type of End User, Industry Players is the Fastest Growing Segment of Biosensors Market

Based on the type of end user, the market is segmented into academic and research institutes and industry players. Currently, academic and research institutes segment captures the highest proportion (~60%) of the biosensors market. Further, industry players' segment is expected to grow at a higher compounded annual growth rate of 10.1% during the forecast period.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and the Rest of the World. Currently, North America (~40%) dominates the biosensors market and accounts for the largest revenue share. Further, the market in Europe is expected to grow at a higher CAGR in the coming years.

Example Players in the Biosensors Market

Agilent Technologies
Axion Biosystems
BioNavigations
Creoptix
Cytiva
Dynamic Biosensors
Malvern Panalytical
Microvacuum
Sartorius
Tempo Bioscience

PRIMARY RESEARCH OVERVIEW

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews conducted with the following industry stakeholders:

Chief Executive Officer, Company A
Chief Executive Officer, Company B
Associate Director R&D, Head of Biology, Company C

GLOBAL BIOSENSORS MARKET: RESEARCH COVERAGE

Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global biosensors market, focusing on key market segments, including [A] type of biosensor, [B] type of end user and [C] key geographical regions.
Market Landscape: A comprehensive evaluation of biosensors in drug discovery, considering various parameters, such as [A] type of biosensor, [B] bioreceptor used, [C] drug discovery step(s) supported, [D] other applications, [E] type of analyte analyzed, [F] type of carrier plate format, [G] sample capacity, [H] sample volume, [I] type of detection and [J] type of system. Additionally, a comprehensive evaluation of biosensor developers based on various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, and [D] leading players (in terms of number of biosensors developed).
Product Competitiveness Analysis: A comprehensive competitive analysis of biosensors used for drug discovery purposes, examining factors, such as [A] supplier power and [B] product competitiveness.
Company Profiles: In-depth profiles companies developing biosensors for drug discovery applications, focusing on [A] company overview, [B] product portfolio and [C] recent developments and an informed future outlook.
Brand Positioning Analysis: In-depth brand positioning analysis of leading industry firms, highlighting the current perceptions regarding their proprietary brands across biosensors in drug discovery.
Funding And Investment Analysis: A detailed analysis of investments that have been made into companies developing biosensors for drug discovery applications, based on various relevant parameters, such as [A] year of investment, [B] the amount invested, [C] type of funding, [D] most active players (in terms of the number of funding instances), and [E] type of investor.
Publication Analysis: An insightful analysis of around 333 peer-reviewed scientific articles related to research on biosensors in drug discovery, based on various relevant parameters, such as [A] year of publication, [B] type of publication, [C] emerging focus areas, [D] most active publishers, [E] most active affiliated institutes and [F] geography.
Global Event Analysis: An in-depth analysis of the global events attended by participants, based on various relevant parameters, such as [A] year of event, [B] type of event platform, [C] location of event, [D] emerging focus areas, [E] active organizers (in terms of number of events), [F] active industry and non-industry participants, [G] designation of participants, and [H] affiliated organizations of participant.
Patent Analysis: An insightful analysis of various patents that have been filed / granted related to biosensors in drug discovery, based on several parameters, such as [A] publication year, [B] geographical region, [C] CPC symbols, [D] patent focus areas, [E] type of applicant, [F] detailed valuation analysis and [G] leading players (in terms of size of intellectual property portfolio).

KEY QUESTIONS ANSWERED IN THIS REPORT

How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older

1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
- 1.2.1. Research Assumptions
- 1.2.2. Project Methodology
- 1.2.3. Forecast Methodology
- 1.2.4. Robust Quality Control
- 1.2.5. Key Considerations
  - 1.2.5.1. Demographics
  - 1.2.5.2. Economic Factors
  - 1.2.5.3. Government Regulations
  - 1.2.5.4. Supply Chain
  - 1.2.5.5. COVID Impact / Related Factors
  - 1.2.5.6. Market Access
  - 1.2.5.7. Healthcare Policies
  - 1.2.5.8. Industry Consolidation
1.3 Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. An Overview of Biosensors
3.3. Components of Biosensors
3.4. Types of Biosensors
3.5. Applications of Biosensors in Drug Discovery
3.6. Challenges Associated with Use of Biosensors in Drug Discovery
3.7. Concluding Remarks

4. MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Biosensors in Drug Discovery: Overall Market Landscape
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Location of Headquarters
- 4.2.4. Most Active Players: Analysis by Number of Biosensors Developed
- 4.2.5. Analysis by Type of Biosensor
- 4.2.6. Analysis by Type of Bioreceptor Used
- 4.2.7. Analysis by Type of Biosensor and Type of Bioreceptor Used
- 4.2.8. Analysis by Drug Discovery Step(s) Supported
- 4.2.9. Analysis by Other Applications Supported
- 4.2.10. Analysis by Type of Analyte
- 4.2.11. Analysis by Carrier Plate Format
- 4.2.12. Analysis by Type of Biosensor and Carrier Plate Format
- 4.2.13. Analysis by Sample Capacity
- 4.2.14. Analysis by Sample Volume
- 4.2.15. Analysis by Type of Detection Method Employed
- 4.2.16. Analysis by Type of System

5. PRODUCT COMPETITIVENESS ANALYSIS

5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Product Competitiveness Analysis: Biosensors in Drug Discovery

6. COMPANY PROFILES: BIOSENSORS DEVELOPERS FOR DRUG DISCOVERY APPLICATIONS

6.1. Chapter Overview
6.2. Agilent Technologies
- 6.2.1. Company Overview
- 6.2.2. Product Portfolio
- 6.2.3. Recent Developments and Future Outlook
6.3. Axion Biosystems
- 6.3.1. Company Overview
- 6.3.2. Product Portfolio
- 6.3.3. Recent Developments and Future Outlook
6.4. BioNavigations
- 6.4.1. Company Overview
- 6.4.2. Product Portfolio
- 6.4.3. Recent Developments and Future Outlook
6.5. Creoptix
- 6.5.1. Company Overview
- 6.5.2. Product Portfolio
- 6.5.3. Recent Developments and Future Outlook
6.6. Cytiva
- 6.6.1. Company Overview
- 6.6.2. Product Portfolio
- 6.6.3. Recent Developments and Future Outlook
6.7. Dynamic Biosensors
- 6.7.1. Company Overview
- 6.7.2. Product Portfolio
- 6.7.3. Recent Developments and Future Outlook
6.8. Malvern Panalytical
- 6.8.1. Company Overview
- 6.8.2. Product Portfolio
- 6.8.3. Recent Developments and Future Outlook
6.9. Microvacuum
- 6.9.1. Company Overview
- 6.9.2. Product Portfolio
- 6.9.3. Recent Developments and Future Outlook
6.10. Sartorius
- 6.10.1. Company Overview
- 6.10.2. Product Portfolio
- 6.10.3. Recent Developments and Future Outlook
6.11. Tempo Bioscience
- 6.11.1. Company Overview
- 6.11.2. Product Portfolio
- 6.11.3. Recent Developments and Future Outlook

7. BRAND POSITIONING ANALYSIS

7.1. Chapter Overview
7.2. Key Parameters
7.3. Methodology
7.4. Biosensor Developers for Drug Discovery Applications
- 7.4.1. Brand Positioning Matrix: Agilent Technologies
- 7.4.2. Brand Positioning Matrix: Cytiva
- 7.4.3. Brand Positioning Matrix: Sartorius
- 7.4.4. Brand Positioning Matrix: Malvern Panalytical

8. FUNDING AND INVESTMENT ANALYSIS

8.1. Chapter Overview
8.2. Types of Funding
8.3. Biosensors in Drug Discovery: Funding and Investments
- 8.3.1. Analysis of Funding Instances by Year
- 8.3.2. Analysis of Amount Invested by Year
- 8.3.3. Analysis of Funding Instances by Type of Funding
- 8.3.4. Analysis of Amount Invested by Type of Funding
- 8.3.5. Analysis of Funding Instances by Type of Biosensor
- 8.3.6. Most Active Players: Analysis by Number of Funding Instances
- 8.3.7. Most Active Players: Analysis by Amount Invested
- 8.3.8. Most Active Investors: Analysis by Number of Funding Instances
- 8.3.9. Analysis of Amount Invested by Geography
  - 8.3.9.1. Analysis by Region
  - 8.3.9.2. Analysis by Country

9. PUBLICATION ANALYSIS

9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Biosensors in Drug Discovery: Publication Analysis
- 9.3.1. Analysis by Year of Publication
- 9.3.2. Analysis by Type of Publication
- 9.3.3. Most Popular Journals: Analysis by Number of Publications
- 9.3.4. Most Popular Journals: Analysis by Impact Factor
- 9.3.5. Analysis by Most Popular Keywords
- 9.3.6. Most Active Publisher: Analysis by Number of Publications
- 9.3.7. Most Active Affiliated Institutes: Analysis by Number of Publications
- 9.3.8. Analysis by Geography

10. GLOBAL EVENT ANALYSIS

10.1. Chapter Overview
10.2. Scope and Methodology
10.3. List of Global Events Related to Biosensors in Drug Discovery
- 10.3.1. Analysis by Year of Event
- 10.3.2. Analysis by Event Platform
- 10.3.3. Analysis by Type of Event
- 10.3.4. Analysis by Location of Event
- 10.3.5. Analysis by Evolutionary Trends in Event Agendas / Key Focus Areas
- 10.3.6. Most Active Organizers: Analysis by Number of Events
- 10.3.7. Analysis by Designation of Participants
- 10.3.8. Analysis by Affiliated Department of Participants
- 10.3.9. Analysis by Geography of Upcoming Events

11. PATENT ANALYSIS

11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Biosensors in Drug Discovery: Patent Analysis
- 11.3.1. Analysis by Publication Year
- 11.3.2. Analysis by Geography
- 11.3.3. Analysis by CPC Symbols
- 11.3.4. Analysis by Emerging Focus Areas
- 11.3.5. Analysis by Patent Age
- 11.3.6. Analysis by Type of Applicant
- 11.3.7. Leading Industry Players: Analysis by Number of Patents
- 11.3.8. Leading Non-Industry Players: Analysis by Number of Patents
- 11.3.9. Leading Individual Assignees: Analysis by Number of Patents
11.4. Biosensors in Drug Discovery: Patent Valuation
11.5. Leading Patents: Analysis by Number of Citations

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Biosensors in Drug Discovery Market, Till 2035
- 12.3.1. Biosensors in Drug Discovery Market: Distribution by Type of Biosensor
  - 12.3.1.1. Optical Biosensors in Drug Discovery Market, Till 2035
  - 12.3.1.2. Electrochemical Biosensors in Drug Discovery Market, Till 2035
  - 12.3.1.3. Thermal Biosensors in Drug Discovery Market, Till 2035
  - 12.3.1.4. Other Biosensors in Drug Discovery Market, Till 2035
- 12.3.2. Biosensor in Drug Discovery Market: Distribution by Type of End User
  - 12.3.2.1. Biosensor in Drug Discovery Market for Academic and Research Institutes, Till 2035
  - 12.3.2.2. Biosensor in Drug Discovery Market for Industry Players, Till 2035
- 12.3.3. Biosensor in Drug Discovery Market: Distribution by Region
  - 12.3.3.1. Biosensor in Drug Discovery Market in North America, Till 2035
  - 12.3.3.2. Biosensor in Drug Discovery Market in Europe, Till 2035
  - 12.3.3.3. Biosensor in Drug Discovery Market in Asia Pacific, Till 2035
  - 12.3.3.4. Biosensor in Drug Discovery Market in Latin America, Till 2035
  - 12.3.3.5. Biosensor in Drug Discovery Market in Middle East and North Africa, Till 2035
  - 12.3.3.6. Biosensor in Drug Discovery Market in Rest of the World, Till 2035

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

14.1. Chapter Overview
14.2. Company A
- 14.2.1. Company Snapshot
- 14.2.2. Interview Transcript: Chief Executive Officer
14.3. Company B
- 14.3.1. Company Snapshot
- 14.3.2. Interview Transcript: Chief Executive Officer
14.4. Company C
- 14.4.1. Company Snapshot
- 14.4.2. Interview Transcript: Associate Director R&D, Head of Biology

バイオセンサー市場：業界動向と世界の予測 - バイオセンサータイプ別、エンドユーザータイプ別、主要地域別

Biosensors Market: Industry Trends and Global Forecasts - Distribution by Type of Biosensors, Type of End User and Key Geographical Regions

世界のバイオセンサー市場：概要

世界のバイオセンサー市場：成長と動向

バイオセンサーの世界市場：主要インサイト

バイオセンサーの世界市場：主要セグメント

バイオセンサー市場の参入企業例

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 イントロダクション

第4章 市場情勢

第5章 製品競争力分析

第6章 企業プロファイル：創薬向けバイオセンサー開発企業

第7章 ブランドポジショニング分析

第8章 資金調達と投資分析

第9章 出版物の分析

第10章 地球規模のイベント分析

第11章 特許分析

第12章 市場予測と機会分析

第13章 結論

第14章 エグゼクティブ洞察

第15章 付録1：表形式データ

第16章 付録2：企業・団体一覧

List of Tables

List of Figures

GLOBAL BIOSENSORS MARKET: OVERVIEW

GLOBAL BIOSENSORS MARKET: GROWTH AND TRENDS

GLOBAL BIOSENSORS MARKET: KEY INSIGHTS

GLOBAL BIOSENSORS MARKET: KEY SEGMENTS

Example Players in the Biosensors Market

GLOBAL BIOSENSORS MARKET: RESEARCH COVERAGE

KEY QUESTIONS ANSWERED IN THIS REPORT

REASONS TO BUY THIS REPORT

ADDITIONAL BENEFITS

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE

5. PRODUCT COMPETITIVENESS ANALYSIS

6. COMPANY PROFILES: BIOSENSORS DEVELOPERS FOR DRUG DISCOVERY APPLICATIONS

7. BRAND POSITIONING ANALYSIS

8. FUNDING AND INVESTMENT ANALYSIS

9. PUBLICATION ANALYSIS

10. GLOBAL EVENT ANALYSIS

11. PATENT ANALYSIS

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

第1章序文

第2章エグゼクティブサマリー

第3章イントロダクション

第4章市場情勢

第5章製品競争力分析

第6章企業プロファイル：創薬向けバイオセンサー開発企業

第7章ブランドポジショニング分析

第8章資金調達と投資分析

第9章出版物の分析

第10章地球規模のイベント分析

第11章特許分析

第12章市場予測と機会分析

第13章結論

第14章エグゼクティブ洞察

第15章付録1：表形式データ

第16章付録2：企業・団体一覧